The Lind Partners is a New York-based investment management firm specializing in post-IPO financing. They focus on providing debt and equity investments to public companies, typically in the range of $1 million to $20 million. The firm's investment strategy targets a diverse range of sectors, including technology, healthcare, and energy.
Notable portfolio companies include Seelos Therapeutics, Magnis Energy Technologies, and Comsovereign Holding. The Lind Partners offers tailored financial solutions to support the growth and expansion of public companies, leveraging their expertise in structured investments and capital markets. Their approach aims to provide flexible funding options while aligning with the long-term objectives of their portfolio companies.
Portfolio Snapshot
Observed round participation, including acquisitions and grants. Current holdings, investor exits, and write-offs are not established.